Phage Therapy BX002 Shows Promise in First-in-human Trial
BX002, an oral phage therapy BiomX is developing for inflammatory bowel disease (IBD), showed a...
Read MoreSelect Page
Posted by Michael Jannicelli | Apr 7, 2023 | Uncategorized | 0 |
BX002, an oral phage therapy BiomX is developing for inflammatory bowel disease (IBD), showed a...
Read MorePosted by Michael Jannicelli | Apr 7, 2023 | Uncategorized | 0 |
Valentine’s Day is in a few days. I told my husband, Patrick, that I wanted to spend the entire...
Read MorePosted by Michael Jannicelli | Apr 7, 2023 | Uncategorized | 0 |
After my second dose of the Moderna COVID-19 vaccine last Friday, I expected days of flu-like...
Read MorePosted by Michael Jannicelli | Apr 7, 2023 | Uncategorized | 0 |
The European Commission (EC) has granted marketing authorization to Celltrion Healthcare‘s Yuflyma...
Read MorePosted by Michael Jannicelli | Apr 7, 2023 | Uncategorized | 0 |
After the toilet paper and hand sanitizer hoarding of 2020, I thought I was equipped for anything....
Read MorePosted by Michael Jannicelli | Apr 7, 2023 | Uncategorized | 0 |
When I returned to teaching full time after my liver transplant, I quickly discovered that the job...
Read More